Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 54 filings.
21 Aug 2026 1 filing
Meeting Details
Date and time: Friday, 28 August 2026, 12:00 Noon–7:00 p.m. IST.
Type and mode: Physical in-person meeting.
Event/organiser: Analysts / Institutional Investors meet.
Participants: Group of Analysts / Institutional Investors.
Purpose: Schedule and discuss the meet.
20 Aug 2026 1 filing
AGM Details
AGM date/time/mode: 18 August 2026, 04:00 PM, VC/OAVM.
Remote e-voting window: 14–17 August 2026; on-site voting 15 minutes post-AGM.
Resolutions and outcomes
Resolution 1 (Ordinary): Adopt audited financials for FY2026; approved with 99.99% in favour.
Resolution 2 (Ordinary): Reappoint Gopalakrishnan Soundarajan; approved with 96.47% in favour.
Director changes
Gopalakrishnan Soundarajan reappointed as director; continues term after rotation.
18 Aug 2026 1 filing
AGM details
Date and mode: 18 August 2026 via VC/OAVM.
Start and end times: 4:05 PM to 4:41 PM.
Quorum: 41 members attended.
Deemed venue: registered office.
Resolutions
Adopt audited financial statements for FY ending 31 March 2026.
Re-appoint director by rotation: Gopalakrishnan Soundarajan.
Voting and results
Remote e-voting conducted 14–17 August 2026; results to be declared.
Results to be filed with stock exchanges and placed on company site.
Directors changes
Director retirement by rotation; re-appointment sought for Gopalakrishnan Soundarajan.
Auditors
Joint statutory auditors expressed unmodified opinions; no changes disclosed.
Other material approvals
No material related-party transactions or ESOP approvals disclosed.
14 Aug 2026 1 filing
Scheme details
Application under 230–232 seeking directions for amalgamation.
Board approved the Scheme on 19.12.2025.
Transferor engages IT consultancy; Transferee operates general and health insurance.
Rationale: simplify structure, reduce shareholding layers, and improve capital access.
First Applicant: authorised Rs 14,00,00,00,000.
First Applicant: issued equity capital Rs 4,62,93,310.
First Applicant: issued preference capital Rs 7,80,00,00,000.
First Applicant: subscribed and paid-up equity Rs 1,02,29,340.
First Applicant: paid-up preference Rs 7,80,00,00,000.
Second Applicant: authorised Rs 10,00,00,00,000.
Second Applicant: issued and paid-up Rs 9,24,49,90,310.
ESOPs: 76,545 equity shares allotted post-31.03.2026.
Exchange ratio: 2,62,589 transferee shares per 1,000 transferor shares.
CCPS exchange: 55,925 and 36,694 transferee shares per 1,000 CCPS.
Transferor equity shares in transferee cancelled on effectiveness.
Meetings: equity shareholders of transferor dispensed; transferee meeting via VC/OAVM within 90 days.
BSE/NSE letters dated 22.04.2026: No Objection for filing Scheme.
Unsecured creditors: Transferor 7 creditors Rs 83,32,714.
Unsecured creditors: Transferee 312 creditors Rs 8,00,99,56,916.
No secured creditors for either company as of 31.03.2026.
Appointed Date fixed as 'Effective Date'.
Order pronounced: 13.08.2026; CA(CAA)/125/2026 allowed.
Regulatory notices to regulators; affidavits of service due within 10 days.
Compliance reports to be filed within 10 days after notices.
11 Aug 2026 1 filing
Meeting Details
Date and time: Friday, 14 August 2026 at 10:00 a.m. IST.
Type/Mode: group meeting with analysts/institutional investors; in-person in Mumbai.
Event/organiser: Emkay Confluence 2026.
Purpose: reiterate Q1 FY2026-27 earnings call details.
Availability: Q1 FY2026-27 investor presentation will be published on the IR site.
30 Jul 2026 1 filing
Financial Performance
Profit after tax (NEP, DAC; no MTM/discounting): INR 190 crores.
Combined ratio NEP with DAC: 107.2%; without discounting: 104.3%.
Net earned premium rose 8% to INR 2,007 crores.
AUM rose about INR 500 crores; asset allocation to AUM 9.5%.
Equity unrealized gains INR 268 crores; fixed-income gains INR 220 crores.
New 2-wheeler premium INR 546 crores; growth 26% in Q1.
Long-term advance premium INR 3,387 crores; motor INR 2,879 crores; non-motor INR 508 crores.
IGAAP net worth INR 4,674 crores; IFRS net worth INR 8,200 crores.
Solvency 2.43x; RBC guidelines awaited.
Operating Update
Motor market share declined to 5.6% in Q1 FY27.
CV business now ~23-24% of motor book.
Fire loss ratio de-grown 37%; industry around -27% to -28%.
OD loss ratio rose to 73.3% in Q1; corrective actions Feb–May.
Group health PA claims inflated due to a large bank-driven PA policy.
GWP declined 8%; ex-health/crop inward reinsurance growth near -2%.
Motor overall flat; 2-wheeler up 26%; CV down 27%.
Retention increased; mix shift to higher retention lines.
Dividend policy tied to RBC norms; potential dividend in Q4 if solvency supports.
Investments and Capital Allocation
Equity allocation 9.5% of AUM; unrealized equity gains INR 268 crores.
Fixed income unrealized gains around INR 220 crores.
Duration moved 4.5 to 4.9; reinvestment yield 7.8%.
Rates rise beyond 7.75%; extend duration to 5.2%.
Q&A Highlights
Question on structural growth; profitability-first approach, not chasing growth.
Question on TP reserve impact of Supreme Court rulings; conservative reserving, ongoing judgments.
Question on large fire/marine/engineering losses; large claim; reinsurers' treatment.
Question on RBC norms and dividend policy; RBC pending; possible Q4 dividend.
Question on NEP retention vs EOM growth; mix effects; profitability-first approach.
Question: 83% TP compromise; 17% court; no MAD; reserves based on frequency and legal inflation.
IRDAI interview suggests reforms; management supportive if customer-friendly.
IFRS publishing for non-life results; aims to ease comparisons.